Profile of patients with fibromyalgia being treated in primary care centers in Terrassa, a city in northeastern Spain.

Autor: Mur Martí T; Medicina de Familia, Centro Atención Primaria Rubí 1, Mútua Terrassa, Rubí, Barcelona, España. Electronic address: tmm637@gmail.com., Llordés Llordés M; Medicina de Familia, Centro Atención Primaria Terrassa Sud, Mútua Terrassa, Terrassa, Barcelona, España., Custal Jordà M; Medicina de Familia, Centro Atención Primaria Rambla, Mútua Terrassa, Terrassa, Barcelona, España., López Juan G; Medicina Familiar y Comunitaria, CAP Terrassa Sud, Mútua Terrassa, Terrassa, Barcelona, España., Martínez Pardo S; Servicio Reumatología, Hospital Universitari Mútua Terrassa, Terrassa, Barcelona, España.
Jazyk: English; Spanish; Castilian
Zdroj: Reumatologia clinica [Reumatol Clin] 2017 Sep - Oct; Vol. 13 (5), pp. 252-257. Date of Electronic Publication: 2016 Jun 29.
DOI: 10.1016/j.reuma.2016.05.008
Abstrakt: Objective: To perform an extensive clinical and epidemiological characterization of our fibromyalgia patients.
Patients, Material, and Method: Two-year observational study in 3 primary care centers in Terrassa, Spain. We recruited a sample of 235 individuals diagnosed with fibromyalgia being treated in primary care or rheumatology clinics who, when offered inclusion in a multidisciplinary program, agreed to provide the initial data we requested. The main measures were sociodemographic data, unhealthy habits and physical activity, comorbidities, treatment for fibromyalgia, Fibromyalgia Impact Questionnaire (FIQ), Hospital Anxiety and Depression Scale (HADS), and a family functioning scale (family APGAR).
Main Results: In all, 97.8% were women and the average age was 54.6 years. Most of the patients had a primary school education and the majority was on sick leave. Ninety-four percent had associated comorbidity and only 3% were not taking any medication for their disease. Many were taking drugs with no proven efficacy in fibromyalgia. The majority had intermediate scores on the FIQ, the HADS showed that 63% and 53% had an anxious and/or probable depressive disorder, respectively, and, according to the family APGAR score, 62% received proper family support.
Conclusions: In agreement with the literature, the major findings in our fibromyalgia patients were a marked predominance of women, a high incidence of comorbidities-mainly psychiatric disorders-a moderate impact of the disease and widespread use of drugs with no demonstrated efficacy.
(Copyright © 2016 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.)
Databáze: MEDLINE